{"id":"W4323362510","doi":"10.1038/s41408-023-00805-x","title":"Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS","year":2023,"lang":"en","type":"letter","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"Janssen Research and Development; National Cancer Institute; Amgen","keywords":"Daratumumab; Carfilzomib; Pleiades; Dexamethasone; Medicine; Oncology; Multiple myeloma; Internal medicine; Refractory (planetary science); Lenalidomide; Biology; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007385256,0.0005420445,0.0008244688,0.0005019301,0.0008989738,0.0008961717,0.0005869947,0.00424693,0.001888172],"category_scores_gemma":[0.001632873,0.0002329388,0.0004887892,0.0006342597,0.0005411632,0.0005858886,0.0002058817,0.003203377,0.0008599853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002279873,"about_ca_system_score_gemma":0.001785742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001700353,"about_ca_topic_score_gemma":0.003641778,"domain_scores_codex":[0.9995148,0.0001053732,0.00006758953,0.00005754835,0.0001656714,0.00008910798],"domain_scores_gemma":[0.999238,0.0002855683,0.0000527474,0.00002614016,0.0001749401,0.0002225963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.004042147,0.001233731,0.01864928,0.0007122942,0.0001328042,0.144463,0.0003515716,0.001152522,0.006374603,0.009214696,0.5205532,0.29312],"study_design_scores_gemma":[0.003256579,0.003859695,0.032841,0.0009069003,0.0004633311,0.1970815,0.000335326,0.007276466,0.005459018,0.01143498,0.7369974,0.00008780223],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1289578,0.09181231,0.002214616,0.7118729,0.01962395,0.0005073218,0.0004435436,0.000182955,0.04438463],"genre_scores_gemma":[0.4541343,0.0602611,0.004942582,0.3697622,0.07736991,0.0004385553,0.001055605,0.00009929822,0.03193645],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.00424693,"threshold_uncertainty_score":0.01654172,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07917735754631587,"score_gpt":0.3615669861534548,"score_spread":0.282389628607139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}